These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18612128)

  • 41. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
    Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
    Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Towards a more precise and individualized assessment of breast cancer risk.
    Wood ME; Farina NH; Ahern TP; Cuke ME; Stein JL; Stein GS; Lian JB
    Aging (Albany NY); 2019 Feb; 11(4):1305-1316. PubMed ID: 30787204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Data on Single Nucleotide Polymorphism of DNA Repair Genes and Breast Cancer Risk from Poland.
    Smolarz B; Bryś M; Forma E; Zadrożny M; Bieńkiewicz J; Romanowicz H
    Pathol Oncol Res; 2019 Oct; 25(4):1311-1317. PubMed ID: 29209986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification.
    Läll K; Lepamets M; Palover M; Esko T; Metspalu A; Tõnisson N; Padrik P; Mägi R; Fischer K
    BMC Cancer; 2019 Jun; 19(1):557. PubMed ID: 31182048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predicting the future of genetic risk prediction.
    Chatterjee N; Park JH; Caporaso N; Gail MH
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):3-8. PubMed ID: 21212066
    [No Abstract]   [Full Text] [Related]  

  • 46. Development of Malignancy-Risk Gene Signature Assay for Predicting Breast Cancer Risk.
    Sun J; Chen DT; Li J; Sun W; Yoder SJ; Mesa TE; Wloch M; Roetzheim R; Laronga C; Lee MC
    J Surg Res; 2020 Jan; 245():153-162. PubMed ID: 31419640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
    Meretoja TJ; Leidenius MH; Heikkilä PS; Boross G; Sejben I; Regitnig P; Luschin-Ebengreuth G; Žgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Vörös A; Saidan ZA; Nadeem RM; Castellano I; Sapino A; Bianchi S; Vezzosi V; Barranger E; Lousquy R; Arisio R; Foschini MP; Imoto S; Kamma H; Tvedskov TF; Kroman N; Jensen MB; Audisio RA; Cserni G
    J Natl Cancer Inst; 2012 Dec; 104(24):1888-96. PubMed ID: 23117131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathway-Affecting Single Nucleotide Polymorphisms (SNPs) in RPS6KA1 and MBIP Genes are Associated with Breast Cancer Risk.
    Shareefi G; Turkistani AN; Alsayyah A; Kussaibi H; Abdel Hadi M; Alkharsah KR
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2163-2168. PubMed ID: 32711446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.
    Terry MB; McDonald JA; Wu HC; Eng S; Santella RM
    Adv Exp Med Biol; 2016; 882():33-68. PubMed ID: 26987530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimating Risk of Recurrence for Early Breast Cancer: Integrating Clinical and Genomic Risk.
    Dowsett M; Turner N
    J Clin Oncol; 2019 Mar; 37(9):689-692. PubMed ID: 30742561
    [No Abstract]   [Full Text] [Related]  

  • 51. Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry.
    Dite GS; MacInnis RJ; Bickerstaffe A; Dowty JG; Allman R; Apicella C; Milne RL; Tsimiklis H; Phillips KA; Giles GG; Terry MB; Southey MC; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):359-65. PubMed ID: 26677205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of breast cancer risk genes and establishment of a prediction model based on estrogen metabolism regulation.
    Zhao F; Hao Z; Zhong Y; Xu Y; Guo M; Zhang B; Yin X; Li Y; Zhou X
    BMC Cancer; 2021 Feb; 21(1):194. PubMed ID: 33632172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic interactions between INPP4B and RAD50 is prognostic of breast cancer survival.
    Chen X; Theobard R; Zhang J; Dai X
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31872854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.
    Tang Q; Holland-Letz T; Slynko A; Cuk K; Marme F; Schott S; Heil J; Qu B; Golatta M; Bewerunge-Hudler M; Sutter C; Surowy H; Wappenschmidt B; Schmutzler R; Hoth M; Bugert P; Bartram CR; Sohn C; Schneeweiss A; Yang R; Burwinkel B
    Oncotarget; 2016 Sep; 7(39):64191-64202. PubMed ID: 27577081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrating of genomic and transcriptomic profiles for the prognostic assessment of breast cancer.
    Yu C; Qin N; Pu Z; Song C; Wang C; Chen J; Dai J; Ma H; Jiang T; Jiang Y
    Breast Cancer Res Treat; 2019 Jun; 175(3):691-699. PubMed ID: 30868394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictive models of choroidal neovascularization and geographic atrophy incidence applied to clinical trial design.
    McCarthy LC; Newcombe PJ; Whittaker JC; Wurzelmann JI; Fries MA; Burnham NR; Cai G; Stinnett SW; Trivedi TM; Xu CF
    Am J Ophthalmol; 2012 Sep; 154(3):568-578.e12. PubMed ID: 22704140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction and Analysis of Breast Cancer Related Deleterious Non-Synonymous Single Nucleotide Polymorphisms in the PTEN Gene.
    Naidu CK; Suneetha Y
    Asian Pac J Cancer Prev; 2016; 17(4):2199-203. PubMed ID: 27221918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of the MTHFR Gene C677T Polymorphism with Breast Cancer in a Turkish Population.
    Kaya EF; Karakus N; Ulusoy AN; Özaslan C; Kara N
    Oncol Res Treat; 2016; 39(9):534-8. PubMed ID: 27614738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination of phenotype and polygenic risk score in breast cancer risk evaluation in the Spanish population: a case -control study.
    Triviño JC; Ceba A; Rubio-Solsona E; Serra D; Sanchez-Guiu I; Ribas G; Rosa R; Cabo M; Bernad L; Pita G; Gonzalez-Neira A; Legarda G; Diaz JL; García-Vigara A; Martínez-Aspas A; Escrig M; Bermejo B; Eroles P; Ibáñez J; Salas D; Julve A; Cano A; Lluch A; Miñambres R; Benitez J
    BMC Cancer; 2020 Nov; 20(1):1079. PubMed ID: 33167914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatocyte Growth Factor in Blood and Gastric Cancer Risk: A Nested Case-Control Study.
    Jang J; Ma SH; Ko KP; Choi BY; Yoo KY; Park SK
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):470-476. PubMed ID: 31740519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.